AzTrials
AzTrials

Therapeutic CommunicationAI-CHAT-PSYNCT07905469

Culturally-Tailored AI Chatbot Simulation for Therapeutic Communication and Empathy in Psychiatric Nursing Students

A study testing Culturally-Tailored AI Chatbot Simulation and Instructor-Facilitated Peer Role-Play in people with Therapeutic Communication, run by Alexandria University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Therapeutic communication and empathy are core competencies in psychiatric nursing, yet students often have limited opportunities to practise them safely with culturally realistic patients and families. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Therapeutic Communication
What is being tested?
Culturally-Tailored AI Chatbot Simulation and Instructor-Facilitated Peer Role-Play
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteEgypt
Study dates
20 Oct 2026to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Officially enrolled in the psychiatric and mental health nursing course (fourth-year undergraduate nursing student, Faculty of Nursing, Alexandria University, first clinical rotation group, first semester 2026/2027) and has not yet started the psychiatric clinical rotation.
  • Regular access to a smartphone, tablet, or computer with a reliable internet connection.
  • Written informed consent.

Who cannot join

  • Formal training in therapeutic communication or motivational interviewing outside the standard curriculum.
  • Previous use of an AI-based psychiatric simulation.
  • Participation in the pilot study.
  • Did not complete the baseline assessment (not randomized).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mohamed Salem, PhD contact

01286038014

Mohamed.Fakhry@alexu.edu.eg

Egypt1 site
  • Faculty of Nursing, Alexandria University

    Alexandria, Alexandria Governorate, 2500

Other trials in Egypt

About this study

Official title: Effectiveness of a Culturally-Tailored AI Chatbot Simulation on Enhancing Therapeutic Communication Competence and Empathy Among Psychiatric Nursing Students: A Randomized Controlled Trial

Therapeutic communication and empathy are core competencies in psychiatric nursing, yet students often have limited opportunities to practise them safely with culturally realistic patients and families. This randomized controlled trial will test whether a culturally tailored, large language model (LLM)-driven AI chatbot simulation improves therapeutic communication competence and empathy among fourth-year nursing students at the Faculty of Nursing, Alexandria University, Egypt.

Being tested
Culturally-Tailored AI Chatbot Simulation, Instructor-Facilitated Peer Role-Play
Keywords
AI chatbot simulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Culturally-Tailored AI Chatbot SimulationBehavioural

    Four weekly individual modules on a secure web-based platform: a 20-minute orientation and three 15-20-minute cases (major depressive disorder, schizophrenia spectrum disorder, bipolar I disorder, manic episode). Students hold free-text conversations with an LLM-driven simulated patient and family member in culturally embedded scenarios (Egyptian colloquial Arabic, idioms of distress, religious explanatory models, family reputation and stigma, medication cost) with bracketed non-verbal cues. Platform features include a Perspective-Taking Drill ("If I were the patient right now, I would feel...") and automated feedback with separate communication and empathy scores. Students follow the Student Clinical Handout, which includes a safety and crisis escalation protocol. Modules are ungraded and an instructor is available in every session.

  • Instructor-Facilitated Peer Role-PlayOther

    Instructor-facilitated role-play in pairs of the same orientation and three cases, matched to the intervention arm in number, order, and length of sessions, using the same Student Clinical Handout. Partners alternate nurse and patient roles using script cards with the same case, cultural content, and cue descriptions; an additional student plays the family member. No AI-embedded Perspective-Taking Drill or automated feedback is provided.

Study groups in NCT07905469
Study groupRoleWhat they receive
AI Chatbot Simulation + Standard CurriculumExperimentalParticipants continue the standard psychiatric nursing curriculum and additionally complete the orientation and three AI-simulated cases individually on the platform, one module per week.
Receives: Behavioral: Culturally-Tailored AI Chatbot Simulation
Peer Role-Play + Standard CurriculumActive comparatorParticipants continue the standard psychiatric nursing curriculum and additionally complete instructor-facilitated peer role-play of the same orientation and three cases, matched in number, order, and length to the intervention arm.
Receives: Other: Instructor-Facilitated Peer Role-Play

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Kiersma-Chen Empathy Scale-Revised (KCES-R)

    Measured: Baseline (one week before the intervention) and immediately after the final simulation module (week 4)

  2. Observer-rated therapeutic communication competence (behavioral checklist total score)

    Measured: Baseline (one week before the intervention) and immediately after the final simulation module (week 4)

Secondary outcomes (1)
  1. Retention of empathy ability: KCES-R Personal Empathy Ability score at four-week follow-up

    Measured: Baseline, immediately after the final module (week 4), and four weeks after the final module

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2026
  2. Study start20 Oct 2026 (estimated)
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07905469
Sponsor's protocol ID
AU-20-10-501
Acronym
AI-CHAT-PSY
Status last verified
Oct 2026
First submitted
16 Oct 2026
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Culturally-Tailored AI Chatbot Simulation and Instructor-Facilitated Peer Role-Play in people with Therapeutic Communication, run by Alexandria University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mohamed Salem, PhD (01286038014, Mohamed.Fakhry@alexu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Kiersma-Chen Empathy Scale-Revised (KCES-R) (time frame: Baseline (one week before the intervention) and immediately after the final simulation module (week 4)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in